Lutèo Medical is pioneering a new class of microbiome-powered therapeutic options in dermatology. Founded in 2025 from research at the University of Manchester, we are addressing the enormous social and economic burden of inflammatory skin disease with a platform of microbiome-derived therapies that restore immune balance, repair barrier function, and prevent disease flares; moving beyond steroids, antibiotics and systemic immunosuppressants with safer, precision disease targeted solutions.